Bristol-Myers Squibb Co (NYSE:BMY) shares traded 1.01% higher at $54.98 on Wall Street last session.
BMY stock price is now -3.89% away from the 50-day moving average and 8.83% away from the 200-day moving average. The market capitalization of the company currently stands at $111.57B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $70, Jefferies recently Upgraded its rating from Hold to Buy for Bristol-Myers Squibb Co (NYSE: BMY). , while ‘Wolfe Research’ rates the stock as ‘Peer Perform’
In other news, Hirawat Samit, EVP,Chief Med.Offr.,Drug Dev. bought 1,823 shares of the company’s stock on Feb 14 ’25. The stock was bought for $100,000 at an average price of $54.84. Upon completion of the transaction, the EVP,Chief Med.Offr.,Drug Dev. now directly owns 63,932 shares in the company, valued at $3.51 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 04 ’24, SVP and Controller Holzer Phil M sold 700 shares of the business’s stock. A total of $38,930 was realized by selling the stock at an average price of $55.62. This leaves the insider owning 11,760 shares of the company worth $0.65 million. A total of 0.14% of the company’s stock is owned by insiders.
During the past 12 months, Bristol-Myers Squibb Co has had a low of $39.35 and a high of $61.10. As of last week, the company has a debt-to-equity ratio of 3.13, a current ratio of 1.25, and a quick ratio of 1.15.
The net profit margin was -18.53% and return on equity was -39.10% for BMY. The company reported revenue of $12.34 billion for the quarter, compared to $11.48 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.54 percent.
